Abediterol
Abediterol (INN; development codes AZD-0548 and LAS 100977) is a once-daily experimental drug candidate for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is currently under development by the Spanish pharmaceutical company Almirall and is in Phase II clinical trials. It acts as a dual β2 adrenergic agonist and muscarinic antagonist and is classified as an ultra-long-acting β2 agonist (ultra-LABA). Its coformulation with mometasone furoate is also in Phase II clinical trials.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Abediterol
Abediterol (INN; development codes AZD-0548 and LAS 100977) is a once-daily experimental drug candidate for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is currently under development by the Spanish pharmaceutical company Almirall and is in Phase II clinical trials. It acts as a dual β2 adrenergic agonist and muscarinic antagonist and is classified as an ultra-long-acting β2 agonist (ultra-LABA). Its coformulation with mometasone furoate is also in Phase II clinical trials.
has abstract
Abediterol (INN; development c ...... o in Phase II clinical trials.
@en
CAS number
915133-65-2
ChEBI
ChEMBL
FDA UNII code
QXA167CM6F
KEGG
PubChem
Wikipage page ID
34,975,653
page length (characters) of wiki page
Wikipage revision ID
1,022,021,141
Link from a Wikipage to another Wikipage
ATC prefix
None
@en
CAS number
ChEBI
ChEMBL
ChemSpiderID
10,136,846
elimination half-life
IUPAC name
KEGG
D10219
@en
PubChem
11,962,616
routes of administration
Inhalation
@en
SMILES
FCCOCCCCCCNC[C@H]c3cccc2c3\C=C/CN2
@en
StdInChIKey
SFYAXIFVXBKRPK-QFIPXVFZSA-N
@en
UNII
QXA167CM6F
@en
Watchedfields
changed
@en
wikiPageUsesTemplate
subject
hypernym
comment
Abediterol (INN; development c ...... o in Phase II clinical trials.
@en
label
Abediterol
@en